Contribution of visceral fat accumulation to the risk factors for atherosclerosis in non-obese Japanese

Internal Medicine

Volumn 43, Issue 12, 2004, Pages 1138-1144

  Miyawaki, Takashi ^a   Abe, Megumi ^a   Yahata, Kensei ^a   Kajiyama, Noboru ^a   Katsuma, Hirokazu ^a   Saito, Nobuo ^a  

^a 11 40 Hijiyamahonmachi   (Japan)

Author keywords

Non obese Japanese; Risk factor for atherosclerosis; Visceral fat

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; JAPAN; LIPID STORAGE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; ORAL GLUCOSE TOLERANCE TEST; POSTPRANDIAL STATE; RISK ASSESSMENT; RISK FACTOR; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; VISCERA; WAIST CIRCUMFERENCE;

ABDOMEN; ADIPOSE TISSUE; ARTERIOSCLEROSIS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; FEMALE; HUMANS; JAPAN; LIPIDS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 11344257833     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.43.1138     Document Type: Article

References (35)

1. Anderson KM, Kannel WB. Obesity and disease. in: Obesity. Björntorp P, Brodoff BN, Eds. JB. Lippincott Company, Philadelphia, 1992: 465-473.
2. Peiris AN, Sothmann MS, Hoffmann RG, et al. Adiposity, fat distribution, and cardiovascular risk. Ann Intern Med 110: 867-872, 1989.
3. Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 36: 54-59, 1987.
4. Matsuzawa Y. Pathophysiology and molecular mechanisms of visceral fat syndrome: The Japanese experience. Diabetes Metab Rev 13 3-13, 1997.
5. Kobayashi H, Nakamura T, Miyaoka K, et al. Visceral fat accumulation contributes to insulin resistance, small-sized low density lipoprotein, and progression of coronary artery disease in middle-aged non-obese Japanese men. Jpn Circ J 65: 193-199, 2001.
6. Yamamoto M, Egusa G, Hara H, Yamakido M. Association of intraabdominal fat and carotid atherosclerosis in non-obese middle-aged men with normal glucose tolerance. Int J Obes Relat Metab Disord 21 948-951, 1997.
7. Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity. New Criteria for 'Obesity Disease' in Japan. Circ J 66: 987-992, 2002.
8. Yoshizumi T, Nakamura T, Yamane M, et al. Abdominal fat: Standardized technique for measurement at CT. Radiology 211: 283-286, 1999.
9. World Health Organizaiton. Diabetes Mellitus: Report of a WHO Study Group. Techinical Report Series no. 727. Geneva, 1985.
10. Nakamura T, Tokunaga K, Shimomura I, et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis 107: 239-246, 1994.
11. Matsuzawa Y, Shimomura I, Nakamura T, Keno Y, Kotani K, Tokunaga K. Pathophysiology and pathogenesis of visceral fat obesity. Obes Res 3 suppl 2: 187S-194S, 1995.
12. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37: 1595-1607, 1988.
13. Kaplan NM. The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 149: 1514-1520, 1989.
14. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 163: 427-436, 2003.
15. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194, 1991.
16. Pouliot MC, Després JP, Nadeau A, et al. Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 41: 826-834, 1992.
17. Yamashita S, Nakamura T, Shimomura I, et al. Insulin resistance and body fat distribution; Contribution of visceral fat accumulation to the development of insulin resistance and atherosclerosis. Diabetes Care 19: 287-291, 1996.
18. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 106: 473-481, 2000.
19. Masuzaki H, Paterson J, Shinyama H, et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 294: 2166-2170, 2001.
20. Björntorp P. "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 10: 493-496, 1990.
21. Bertin E, Nguyen P, Guenounou M, Durlach V, Potron G, Leutenegger M. Plasma levels of tumor necrosis factor-alpha (TNF-α are essentially dependent on visceral fat amount in type 2 diabetic patients. Diabetes Metab 26: 178-182, 2000.
22. Katsuki A, Sumida Y, Murashima S, et al. Serum levels of tumor necrosis factor-α are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol and Metab 83 859-862, 1998.
23. Hotta K, Funahashi T, Bodkin NL, et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type-2 diabetes in rhesus monkeys. Diabetes 50: 1126-1133, 2001.
24. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol and Metab 86: 1930-1935, 2001.
25. McTernan PG, McTernan CL, Chetty R, et al. Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab 87: 2407, 2002.
26. Keno Y, Matsuzawa Y, Tokunaga K, et al. High sucrose diet increases visceral fat accumulation in VMH-lesioned obese rats. Int J Obes 15: 205-211, 1991.
27. Marniemi J, Kronholm E, Aunola S, et al. Visceral fat and psychosocial stress in identical twins discordant for obesity. J Intern Med 251: 35-43, 2002.
28. Shimomura I, Tokunaga K, Kotani K, et al. Marked reduction of acyl-CoA synthetase activity and mRNA in intra-abdominal visceral fat by physical exercise. Am J Physiol 265: E44-50, 1993.
29. Shimokata H, Muller DC, Andres R. Studies in the distribution of body fat. III. Effects of cigarette smoking. JAMA 261: 1169-1173, 1989.
30. Pouliot MC, Després JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthoropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 73: 460-468, 1994.
31. Han TS, van Leer EM, Seidell JC, Lean ME. Waist circumference action levels in the dentification of cardiovascular risk factors: prevalence study in a random sample. BMJ 311: 1401-1405, 1995.
32. Lean ME, Han TS, Seidell JC. Impairment of health and quality of life in people with large waist circumference. Lancet 351: 853-856, 1998.
33. World Health Organizaiton. The Asia-Pacific perspective; Redefining obesity and its treatment. Steering Committee of the Western Pacific Region of the WHO, the Internaitonal Association for the Study of Obesity, and the International Obesity Task Force. Melbourne. Australia, 2000.
34. Kotani K, Tokunaga K, Fujioka S, et al. Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Int J Obes Relat Metab Disord 18: 207-212, 1994.
35. Han TS, Lean MEJ. Self-reported waist circumference compared with the 'Waist Watcher' tape-measure to identify individuals at increased health risk through intra-abdominal fat accumulation. Br J Nutr 80: 81-88, 1998.